We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Report on how community pharmacies can improve the prevention, early detection and management of blood pressure.
Information on medical facilities available in Timor-Leste.
Outlines the level of payment due from members of the Pharmaceutical Price Regulation Scheme (PPRS) in 2018.
A letter providing guidance on the post-transition conversion process was sent by email on 23 October 2020 to the Community MA holders.
Which product type to select when submitting a notification of intent to market e-cigarette and vape products in Northern Ireland.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2022.
A document for patients explaining how the highest risk patient groups eligible for new coronavirus treatments will be identified.
Information on the measures in the Health Service Medical Supplies (Costs) Bill.
Information for healthcare professionals, patients, and the public.
Guidance on applying for a Marketing Authorisation for Decentralised Manufacture, including eligibility, process, and requirements.
We use decades of experience in safe bioagent handling to support partners in research, development and testing of vaccines and therapeutics
Applying for market authorisation for plasma master files (PMFs) and vaccine antigen master files (VAMFs).
Collecting and acting on information on any adverse effects of electronic cigarette devices and refill containers on human health.
Guidance on moving medicines by air
We are allowing alternative courses of actions for manufacturing or laboratory equipment during the outbreak.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2023.
Guidance for industry on flexible approaches we are taking on good distribution practices.
How to report adverse incidents involving insulin infusion pumps and integrated meter systems under the vigilance system.
Apply now to join the AI Airlock pilot by the MHRA. Benefit from industry and regulatory expert collaboration, bespoke testing plans, and improved regulatory understanding.
How equipment for temperature screening is regulated, the limitations of temperature screening for detecting COVID-19 and advice on buying and using these products.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).